Thiotepa Riemser Uniunea Europeană - română - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agenți antineoplazici - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

FERINJECT 50 mg fer/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ferinject 50 mg fer/ml

vifor france - franta - realizat carboxymaltosum - dispersie inj./perf. - 50mg/ml - preparate cu fer fer trivalent,preparate parenterale

XABOGARD 50 mg fer/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

xabogard 50 mg fer/ml

lek pharmaceuticals d.d. - slovenia - realizat carboxymaltosum - sol inj./perf. - 50mg/ml - preparate cu fer fer trivalent,preparate parenterale

XABOGARD 50 mg fer/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

xabogard 50 mg fer/ml

lek pharmaceuticals d.d. - slovenia - realizat carboxymaltosum - sol inj./perf. - 50mg/ml - preparate cu fer fer trivalent,preparate parenterale